GERN
Geron Corp
Price:  
1.41 
USD
Volume:  
16,679,486.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN EV/EBITDA

-210.4%
Upside

As of 2026-03-31, the EV/EBITDA ratio of Geron Corp (GERN) is -20.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GERN's latest enterprise value is 1,072.85 mil USD. GERN's TTM EBITDA according to its financial statements is -51.45 mil USD. Dividing these 2 quantities gives us the above GERN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.2x - 15.1x 14.2x
Forward P/E multiples 15.3x - 20.2x 17.9x
Fair Price (1.49) - (1.47) (1.56)
Upside -206.0% - -204.6% -210.4%
1.41 USD
Stock Price
(1.56) USD
Fair Price

GERN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-03-25 -22.84
2026-03-24 -22.10
2026-03-23 -22.47
2026-03-20 -21.47
2026-03-19 -22.59
2026-03-18 -22.59
2026-03-17 -23.46
2026-03-16 -23.84
2026-03-13 -22.97
2026-03-12 -23.22
2026-03-11 -23.96
2026-03-10 -23.59
2026-03-09 -23.46
2026-03-06 -22.34
2026-03-05 -20.98
2026-03-04 -21.60
2026-03-03 -21.22
2026-03-02 -22.59
2026-02-27 -24.21
2026-02-26 -23.84
2026-02-25 -24.71
2026-02-24 -27.57
2026-02-23 -25.33
2026-02-20 -26.70
2026-02-19 -27.20
2026-02-18 -27.45
2026-02-17 -25.71
2026-02-13 -23.84
2026-02-12 -23.59
2026-02-11 -23.34
2026-02-10 -23.46
2026-02-09 -23.34
2026-02-06 -22.34
2026-02-05 -21.47
2026-02-04 -21.60
2026-02-03 -22.10
2026-02-02 -22.47
2026-01-30 -20.35
2026-01-29 -20.35
2026-01-28 -19.85
2026-01-27 -20.48
2026-01-26 -20.35
2026-01-23 -20.48
2026-01-22 -20.85
2026-01-21 -19.98
2026-01-20 -19.48
2026-01-16 -19.61
2026-01-15 -19.48
2026-01-14 -20.10
2026-01-13 -19.61